NASDAQ:NSPH (NSPH) (NSPH) Stock Price, News & Analysis → Automatic Income (from home) (From Awesomely, LLC) (Ad) Free NSPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$1.69▼$1.6950-Day Range N/A52-Week Range$0.48▼$3.64VolumeN/AAverage Volume886,293 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (NSPH) alerts: Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. About (NSPH) Stock (NASDAQ:NSPH)Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market.Read More Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. NSPH Stock News HeadlinesApril 29, 2024 | msn.comFirst profit for Vinted as young shoppers turn their backs on fast fashionApril 29, 2024 | msn.comStretch your grocery dollars at May commissary sidewalk salesMay 4, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. April 22, 2024 | msn.comChris Stewart endorses 3rd Congressional District candidateApril 22, 2024 | msn.comOlive oil: alternatives for the 'liquid gold'April 13, 2023 | msn.comLIVE FEED: Police, Correctional Services give update on Thabo Bester, Dr Nandipha Magudumana’s arrestsMarch 8, 2023 | msn.comMichelle Yeoh deletes post some saw as a slam on fellow Oscar nominee Cate BlanchettDecember 29, 2022 | msn.comTitans' Teair Tart takes a spill trying to celebrate fumble vs. CowboysMay 4, 2024 | Awesomely, LLC (Ad)Automatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. December 17, 2022 | msn.comPolls open in Tunisian parliamentary election boycotted by oppositionDecember 17, 2022 | msn.comTop 10 customer hacks making workers’ lives miserableNovember 21, 2022 | msn.comSan Mateo: After 40 years, Windy City restaurant, Da Bears fan hangout closes todayAugust 20, 2022 | thestreet.com8 Stocks Under $10 Surging HigherAugust 18, 2022 | msn.comNitish Kumar snubs BJP’s ‘jungle raj returns’ allegation, says will respond at an appropriate timeAugust 6, 2022 | msn.comMore afternoon downpours and storms SundayDecember 14, 2021 | usnews.comLogic's Hit '1-800-273-8255' May Have Saved American LivesSee More Headlines Receive NSPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (NSPH) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/16/2016Today5/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:NSPH CUSIPN/A CIK1105184 Webwww.nanosphere.us Phone+1-847-4009000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report NSPH Stock Analysis - Frequently Asked Questions How were (NSPH)'s earnings last quarter? (NSPH) (NASDAQ:NSPH) released its quarterly earnings results on Monday, May, 16th. The medical research company reported ($0.55) EPS for the quarter, beating analysts' consensus estimates of ($0.59) by $0.04. The medical research company had revenue of $6.60 million for the quarter, compared to analysts' expectations of $6.50 million. The firm's revenue for the quarter was up 43.5% on a year-over-year basis. During the same quarter last year, the firm earned ($1.29) earnings per share. What other stocks do shareholders of (NSPH) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (NSPH) investors own include Cerus (CERS), Aeterna Zentaris (AEZS), Actinium Pharmaceuticals (ATNM), BIOLASE (BIOL), Molecular Templates (MTEM), Northwest Biotherapeutics (NWBO), Sarepta Therapeutics (SRPT), XOMA (XOMA), Cypress Semiconductor (CY) and Equity Bancshares (EQBK). This page (NASDAQ:NSPH) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (NSPH) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
